false 0001695473 0001695473 2025-04-03 2025-04-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

April 3, 2025

Date of Report (Date of earliest event reported)

 

The Greater Cannabis Company Inc.

(Exact Name of Registrant as Specified in Charter)

 

Florida   000-56027   30-0842570

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

15 Walker Ave, Suite 101

Baltimore, MD 21208

(Address of Principal Executive Offices)

 

(443) 738-4051

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   GCAN   None

Emerging Growth Company

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this “Current Report”), and unless otherwise indicated, the terms “the Company,” “GCAN,” “we,” “us” and “our” refer to The Greater Cannabis Company, Inc. and its subsidiaries.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The disclosure set forth in Item 5.02 of this Current Report is incorporated herein by reference.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 3, 2025, GCAN issued 100,000,000 restricted shares of its common stock (the “Shares”) to Aitan Zacharin, its Chief Executive Officer and director, in satisfaction of $10,000 in deferred compensation due him.

 

The Company issued the Shares pursuant to the exemption from the registration requirements of the Securities Act of 1922, as amended (the “Securities Act”), afforded by Section 4(a)(2) of the Securities Act.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  The Greater Cannabis Company, Inc.
a Florida corporation
   
Dated: April 10, 2025 By: /s/ Aitan Zacharin
    Chief Executive Officer